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Abstract: Patients with multiple sclerosis (MS) commonly exhibit cognitive impairments (CI).
However, the neural mechanisms underlying CI remain unclear. The current study applied diffusion
tensor imaging (DTI) and voxel-based morphometric (VBM) magnetic resonance imaging (MRI)
techniques to evaluate differences in white matter (WM) integrity and gray matter (GM) volume
between MS patients with CI and MS patients with cognitive preservation (CP). Neuropsychological
assessment and MRI were obtained from 39 relapsing-remitting MS (RRMS) patients and 29 healthy
controls (HCs). Patients were classified as CI or CP according to cognitive ability, and demographic
characteristics and MRI images were compared. Compared with HCs, MS patients exhibited
widespread damage in WM integrity, and GM loss in several regions. Compared with CP patients,
CI patients exhibited more extensive WM impairments, particularly in the corpus callosum,
cerebellar peduncle, corona radiata, optic radiation, superior longitudinal fasciculus, anterior limb of
the internal capsule, and cingulate, as well as decreased GM volume in the bilateral caudate, left insula
and right temporal lobe. MS patients with CI exhibited more significant structural abnormalities than
those with CP. Widespread impairments of WM integrity and selective GM atrophy both appear to
be associated with impaired cognition in RRMS.
Keywords: multiple sclerosis; cognitive impairment; diffusion tensor imaging; voxel-based
morphology
1. Introduction
Multiple sclerosis (MS) is a demyelination disease affecting the central nervous system (CNS),
typically characterized by motor and sensory dysfunction, and optic neuritis. Previous studies reported
that 40%–70% of MS patients also exhibit cognitive impairments (CI), primarily in learning, memory,
information processing speed, and executive functions [1].
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CI can occur in the early stages of the disease course, even among newly diagnosed patients,
and typically has severe detrimental impacts on patients’ lives [2,3]. Previous studies hypothesized
that CI is associated with the extent of white matter (WM) lesion load in MS patients [4], based on
the volume of T2 (transverse relaxation time) lesions visible on conventional MR imaging. However,
several studies reported a weak relationship between WM damage and cognitive changes [5–7]. Later,
several studies using diffusion tensor imaging (DTI) reported that widespread subtle pathological
changes in WM microstructures (normal appearing WM; NAWM) exhibited a significant correlation
with CI, whereas T2-hyperintense lesions of MS did not [8]. In addition, researchers proposed that
fractional anisotropy (FA) in the uncinate fasciculus was associated with processing speed and spatial
memory [9], and Hulst et al. found that WM integrity was related to cognition in CI–MS patients [10].
Extensive gray matter (GM) loss has been widely reported in patients with MS, including
cortical and deep GM. Asymmetric left-sided loss of GM in the left fronto-temporal cortex and
precuneus, as well as bilateral anterior cingulate gyrus and caudate nuclei atrophy, were reported in
relapsing-remitting MS (RRMS) [11]. Moreover, an association between decreased GM volume and
cognitive impairment was also reported. Several studies of MS patients have revealed a relationship
between CI and deep GM atrophy in a range of areas, including the thalamus, hippocampus,
caudate nucleus, globus pallidus, and basal ganglia, based on voxel-based morphometric (VBM)
analysis, which allows quantification of GM volumes in vivo [12–14]. However, Hulst et al. reported
that only WM integrity was significantly different between CI and cognitive preservation (CP) patients,
while no difference in regional GM volume was found [10]. However, both RRMS and secondary
progressive MS (SPMS) patients were enrolled in Hulst’s study [10]. Previous research indicated that
cognition in SPMS patients was more frequently and severely impaired than among RRMS patients [15].
Thus, the inclusion of different disease subtypes of MS may have affected the results.
The neural mechanisms underlying CI in MS remain controversial. The discrepancy between
previous results may be related to the different types of MS included in study samples. Thus, the current
study aimed to further explore the neural basis of cognitive impairment by distinguishing CI and CP
groups of RRMS patients according to cognitive ability, and examining them with a combination of
DTI and VBM techniques.
2. Results
2.1. Multiple Sclerosis (MS) Patients vs. Healthy Controls (HCs)
2.1.1. Comparison of Cognitive Test Scores
Correcting for Hamilton Anxiety (HAMA) and Hamilton Depression (HAMD) scores, MS patients
exhibited worse performance in the Symbol digit modalities test (SDMT) and PASAT 3 seconds
(PASAT-3”) compared with HCs. These two tests primarily reflect information processing speed and
working memory (Table 1).
2.1.2. White Matter Diffusion Changes—MS Patients vs. HCs
Tract-based spatial statistics (TBSS) detected significantly decreased fractional anisotropy (FA)
and increased mean diffusivity (MD) and radial diffusivity (RD) in many WM tracts in MS patients
compared with HCs. However, increased axial diffusivity (AD) was found to be restricted to a small
number of WM tracts. Comparison of individual voxels of the WM skeleton between MS patients and
HCs [10] revealed decreased FA values in 74% of the investigated WM. In addition, increased MD,
RD, and AD were found in 68%, 79%, and 30% of the investigated WM, respectively, in MS patients
compared with HCs (Figure 1, blue bars).
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Table 1. Comparison of cognition between MS patients and HC.
Cognitive Test HC (n = 29) MS Patients (n = 39) p
AVLT-Total recall 0 ± 1.00 −0.60 ± 1.51 0.294
AVLT-Delayed recall 0 ± 1.00 −0.50 ± 1.44 0.588
VFT 0 ± 1.00 −0.31 ± 0.87 0.892
SDMT 0 ± 1.00 −0.83 ± 1.27 0.014
TMT-A 0 ± 1.00 0.78 ± 1.97 0.290
TMT-B 0 ± 1.00 0.79 ± 1.90 0.254
BVMT-R-Total recall 0 ± 1.00 −0.79 ± 1.80 0.194
BVMT-R-Delayed recall 0 ± 1.00 −0.58 ± 1.79 0.661
PASAT-3” 0 ± 1.00 −0.83 ± 1.50 0.039
JLOT 0 ± 1.00 0.06 ± 0.81 1.000
Values are mean ± standard deviation (SD); Abbreviations: AVLT = Auditory Verbal Learning Test;
VFT = Verbal Fluency Test; SDMT = Symbol digit modalities test; TMT = Trail making test; BVMT-R = Brief
Visuo-patial Memory Test-Revised; PASAT-3” = Paced Auditory Serial Addition Test (3 seconds);
JLOT = Judgment of Line Orientation Test; HC = healthy control.
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Figure 1. Extent of white matter (WM) integrity damage in diffusion tensor images (DTI) analyses. 
The bars indicate the extent of WM integrity damage. The blue and red bars indicate differences of 
WM diffusion between the multiple sclerosis (MS) patients and healthy control (HC) subjects, and 
between the cognitive impairment (CI) and cognitive preservation (CP) groups, respectively. FA, 
MD, RD, and AD refer to fractional anisotropy, mean diffusivity, radial diffusivity, and axial 
diffusivity, respectively. FA: fractional anisotropy; MD: mean diffusivity; RD: radial diffusivity; AD: 
axial diffusivity. 
2.1.3. Voxel-Based Morphometric (VBM) Comparison—MS Patients vs. HCs 
VBM analysis revealed GM volume decreases in several regions in MS patients compared with 
HCs, including the right insula, middle frontal gyrus, inferior frontal gyrus and left cingulate gyrus 
(p < 0.05, family-wise error (FWE) corrected for multiple comparisons, see Table 2 and Figure 2). 
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Figure 1. Extent of white matter (WM) integrity damage in diffusion tensor images (DTI) analyses.
The bars indicate the extent of WM integrity damage. The blue and red bars indicate differences
of WM diffusion between the multiple sclerosis (MS) patients and healthy control (HC) subjects,
and between the cognitive impairment (CI) and cognitive preservation (CP) groups, respectively.
FA, MD, RD, and AD refer to fractional anisotropy, mean diffusivity, radial diffusivity, and axial
diffusivity, respectively. FA: fractional anisotropy; MD: mean diffusivity; RD: radial diffusivity; AD:
axial diffusivity.
2.1.3. Voxel-Based Morphometric (VBM) Comparison—MS Patients vs. HCs
VBM analysis revealed GM volume decreases in several regions in MS patients compared with
HCs, including the right insula, middle frontal gyrus, inferior frontal gyrus and left cingulate gyrus
(p < 0.05, family-wise error (FWE) corrected for multiple comparisons, see Table 2 and Figure 2).
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Table 2. The decreased volumes of gray matter (GM) in MS patients compared to HCs (pFWE correction < 0.05).
Brain Region Number of Voxels (mm3)
Peak MNI Coordinate Brodmann
T Value
x y z Area
Right insula 75 45 −9 12 13 5.36
Right inferior frontal gyrus 205 22 15 −24 47 5.56
Right middle frontal gyrus 268 43 18 39 9 5.68
Left cingulate gyrus 195 −7 −15 43 24 5.52
Each cluster represents the extension where local maxima are located, along with the MNI coordinates, and the
T values of the most significant voxel are reported. A threshold of p < 0.05 is set for the data, and the data are
corrected using the false discovery rate (FDR). MNI = Montreal Neurological Institute; FWE = family-wise error.
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Decreased FA values and increased MD and RD values were observed in a large number of 
WM tracts across the brain in CI compared with CP patients (Figure 1). FA was decreased in 44% of 
the studied WM, and almost all the areas exhibiting decreased FA overlapped with areas exhibiting 
increased MD and RD. Statistical analyses revealed that MD and RD values were increased by 51% 
and 55%, respectively, in the CI group compared with the CP group (Figure 1, red bars). However, 
the areas showing increased AD (30% of the investigated WM) were restricted to a small number of 
WM tracts, including the corpus callosum, corona radiata, external capsule, superior longitudinal 
fasciculus, anterior limb of internal capsule, middle cerebellar peduncle, fornix (cres)/stria 
terminalis. In addition, these areas overlapped with regions exhibiting reduced FA, increased MD 
and RD (pFWE correction < 0.05) (Figure 3 and Table 3). 
Table 3. WM diffusion changes between CI and CP groups (pFWE correction < 0.05). 
White Matter Tracts FA ↓ MD ↑ RD ↑ AD ↑ 
Cerebellar peduncle 
Superior-R Superior-L Superior-Bilateral – 
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Figure 2. Statistical parametric mapping (SPM) regions with decreased gray matter (GM) volume in
patients compared with healthy controls (p < 0.05, family-wise error (FWE) corrected for multiple
comparisons). SPM regions exhibiting significant GM loss: right insula (A); right inferior frontal
gyrus (B); right middle frontal gyrus and left cingulate gyrus (C). R: right; L: left.
2.2. Imaging Comparison—CI-MS Patients vs. CP-MS Patients
2.2.1. White Matter Diffusion Changes—MS Patients CI vs. CP
Decreased FA values and increased MD and RD values were observed in a large number of
WM tracts across the brain in CI compared with CP patients (Figure 1). FA was decreased in 44% of
the studied WM, and almost all the areas exhibiting decreased FA overlapped with areas exhibiting
increased MD and RD. Statistical analyses revealed that MD and RD values were increased by 51% and
55%, respectively, in the CI group compared with the CP group (Figure 1, red bars). However, the areas
showing increased AD (30% of the investigated WM) were restricted to a small number of WM tracts,
including the corpus callosum, corona radiata, external capsule, superior longitudinal fasciculus,
anterior limb of internal capsule, middle cerebellar peduncle, fornix (cres)/stria terminalis. In addition,
these areas overlapped with regions exhibiting reduced FA, increased MD and RD (pFWE correction < 0.05)
(Figure 3 and Table 3).
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for multiple comparisons). 
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Right temporal lobe 117 42 18 −22 38 7.29 
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Right caudate 137 12 16 10 NA 6.66 
Left caudate 74 −13 10 16 NA 6.65 
Each cluster represents the extension where local maxima are located, along with the MNI 
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Figure 3. Tract-based spatial statistics (TBSS) analysis results of diffusion metrics images throughout
the skeleton in CI patients compared with MS patients with CP. R: right; L: left. Red represents
regions with decrease fractional anisotropy (FA), increased mean diffusivity (MD), increased radial
diffusivity (RD) and increase axial diffusivity (AD) in CI patients with MS (p < 0.05, FWE corrected for
multiple comparisons).
Table 3. WM diffusion changes between CI and CP groups (pFWE correction < 0.05).
White Matter Tracts FA ↓ MD ↑ RD ↑ AD ↑
Cerebellar peduncle
Superior-R Superior-L Superior-Bilateral –
Middle Middle Middle Middle
Inferior-R – – –
External capsule Bilateral Bilateral Bilateral Bilateral
Corona radiata Bilateral Bilateral Bilateral Bilateral
Corpus callosum Genu, body andsplenium
Genu, body and
splenium
Genu, body and
splenium
Genu, body and
splenium
Optic radiation Bilateral Bilateral Bilateral –
Anterior limb of IC Bilateral Bilateral Bilateral Bilateral
Cingulate Bilateral Bilateral Bilateral –
Superior longitudinal
fasciculus Bilateral Bilateral Bilateral Bilateral
Fornix (cres)/Stria
terminalis Bilateral Bilateral Bilateral Bilateral
Abbreviations: CI = cognitive impairment; CP = cognitive preservation; WM = white matter; IC = internal
capsule; L = Left; R = Right; ↓ indicates decreased; ↑ indicates increased.
2.2.2. Comparisons of VBM between CI–MS Patients and CP–MS Patients
The VBM analysis indicated that GM volume significantly decreased in several regions, including
the right temporal lobe, left insula and bilateral caudate in the CI group compared with the CP group
(Table 4 and Figure 4).
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Table 4. The decreased volumes of GM in CI patients compared with the CP group (pFWE correction < 0.05).
Brain Region Number of Voxels (mm3)
Peak MNI Coordinate Brodmann
T Value
x y z Area
Right temporal lobe 117 42 18 −22 38 7.29
Left insula 70 −31 19 −4 13 7.30
Right caudate 137 12 16 10 NA 6.66
Left caudate 74 −13 10 16 NA 6.65
Each cluster represents the extension where local maxima are located, along with the MNI coordinates, and the
T values of the most significant voxel are reported. A threshold of p < 0.05 is set for the data, and the data are
corrected using the false discovery rate (FDR). MNI = Montreal Neurological Institute; FWE = family-wise error;
NA = not applicable.Int. J. Mol. Sci. 2017, 18, 46 6 of 13 
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caudate (A); left insula (B); bilateral caudate (C).
3. Discussion
The current study revealed several main findings. First, MS patients exhibited worse performance
on the SDMT and PASAT-3” compared with HCs. We found extensive WM damage, including cortical
and subcortical GM atrophy in the right insula, middle frontal gyrus, inferior frontal gyrus and left
cingulate gyrus in MS patients compared with HCs. In addition, CI–MS patients exhibited worse
performance on the Auditory Verbal Learning Test (AVLT), Verbal Fluency Test (VFT), PASAT-3”,
Brief Visuospatial Memory Test (BVMT), and Trail making test (TMT) compared with CP–MS patients.
CI–MS patients showed a widespread reduction in FA values in many WM tracts throughout the
skeletons, compared with CP–MS patients. The results also revealed regional GM atrophy in several
regions, including the right temporal lobe, left insula and bilateral caudate.
The current results revealed a significant difference in SDMT and PASAT-3” performance
between MS and HC, which primarily reflects information processing speed and working memory
performance. This finding is consistent with previous reports [1,16]. Moreover, we found widespread
WM impairment, as well as cortical and subcortical GM loss in a number of areas, including the
insula, frontal gyrus and cingulate gyrus, in accord with a number of previous studies [10–12,17–20].
Both WM and GM abnormities are known to be involved in MS.
Further analyses revealed significant differences in verbal fluency, speed of information processing,
executive function, and spatial memory between CI–MS and CP–MS patients, in accord with
previous studies [10,21]. In addition, the CI group exhibited widespread WM microstructure
dysfunction compared with the CP group in a range of brain regions, including the corpus callosum,
cerebellar peduncle, corona radiata, optic radiation, superior longitudinal fasciculus, the anterior limb
of the internal capsule, and the cingulate. The corpus callosum has previously been implicated in the
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speed of information processing, executive function, and verbal fluency [22]. In addition, damage to
the optic radiation and superior longitudinal fasciculus have been associated with spatial memory
deficits [23,24]. Hulst et al. reported a 76% decrease in FA in the WM of CI patients, and a 49% FA
decrease in the WM of CP patients. On the basis of these results, the authors speculated that WM
damage was related to CI–MS [10]. The current results further support the notion that WM damage is
associated with cognitive dysfunction in MS.
However, no significant difference in GM volume was found between CI and CP patients in
Hulst’s study, and the authors proposed that GM was not related to cognitive deficits in MS [10].
The current results revealed significant decreased GM volume, including in the right temporal lobe,
left insula and bilateral caudate nucleus in CI patients compared with CP patients. The caudate nucleus
has been found to be related to verbal fluency, language learning and memory [25], and the temporal
lobe is implicated in memory function and information processing speed [12,24,26]. The current results
indicate that atrophy of the right temporal pole, left insula and bilateral caudate nucleus may be
related to CI in RRMS. The discrepancy may be related to the different disease subtypes of MS patients
between the two studies.
In addition, the results revealed that CI–MS patients had a lower educational level, as well as
more severe clinical disability and mental dysfunction, including anxiety and depression, compared
with CP–MS patients. These findings are consistent with several previous reports suggesting that
lower educational level, higher Expanded Disability Status Scale (EDSS)score and more severe mental
dysfunction are related to CI [27–29]. A 5-year neuropsychological longitudinal study of patients
with MS reported no significant change in the speed of information processing in a group of patients
with more than 14 years of education, whereas patients with less than 14 years of education exhibited
significant declines in information processing speed [30]. Similarly, a recent 4.5-year follow-up study
indicated that increased intellectual enrichment contributed to resilience against disease-related
cognitive decline [31]. In addition, compared with CP–MS patients, CI–MS patients exhibited more
severe physical disabilities and abnormal moods including anxiety and depression. Previous studies
reported that fatigue and abnormal mood, particularly depression, can affect patients’ cognitive
function, quality of life and medical compliance [27,32]. Taken together, these findings highlight the
importance of treatment for abnormal mood, particularly depression, among MS patients.
The present study involved several limitations. First, the CI patient sample size was relatively
small; Second, the study did not implement a uniform set of criteria for distinguishing CI–MS patients.
Most previous studies used >1.5 or 2 standard deviations (SDs) below normal data in at least two
cognitive domains for identifying CI. In the current study, we used 1.5 SDs as the threshold, to enable
the detection of mild CI; Third, this was a single center study. Since all patients were enrolled in the
study via tertiary referrals, selection bias may have caused the sample to be non-representative of the
wider population. It would be useful for future studies involving multiple centers and a larger study
population to validate the current results. In addition, future studies should use more strict criteria for
identifying CI (e.g., >2 SDs, or impairment in at least three cognitive domains).
It should be noted that cortical lesions were not measured in our studies and lesion-filling was
not implemented either. Previous investigations have shown that lesion-filling could improve the
accuracy of WM and GM volume measurements [33]. However, there is controversy about the lesion
filling approach in MS. Some researchers have argued that hypointensity WM lesions in MS could be
misclassified as GM in tissue segmentation that increase the measured GM volume [34,35]. In contrast,
some others believe that all GM volumes except for hippocampus had smaller volumes in the original
image compared to the lesion-filled image in MS patients [36]. Moreover, lesion volumes were usually
identified manually, and this process might increase the subjective errors.
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4. Materials and Methods
4.1. Participants
We consecutively enrolled 39 patients diagnosed with clinically definite MS with a
relapsing-remitting course at the outpatient clinic of the PLAGH (The General Hospital of Chinese
People’s Liberation Army) between June 2013 and December 2015. All patients were required
to meet the following inclusion criteria: aged 20–55 years old, meeting the revised McDonald
Diagnostic Criteria for MS [37], and no relapse within 4 weeks of testing. The exclusion criteria
were as follows: metabolic or other CNS disorders with known effects on cognition, taking treatment
involving steroids (prednisone > 10 mg), history of alcohol abuse or psychiatric disorders other than
depression, traumatic brain injury, inability to finish neuropsychological testing because of visual
acuity impairment, or MRI incompatibility (e.g., pacemaker, claustrophobia). Additionally, 29 age-,
gender-, and education-matched HCs without a history of neurological diseases and with normal MRI
scans were recruited. All participants underwent extensive neuropsychological, anxiety and depression
evaluation and multimodal 3.0 Tesla MRI scanning. Histories pertinent to patients’ demographic
and clinical characteristics, including disease duration, annualized relapse rate, and EDSS scores,
were evaluated by an experienced neurologist. The study was approved by the ethics committee of the
Chinese PLA General Hospital (S2013-121-01, 20 May 2013). All participants gave written informed
consent. The demographic and clinical data of all subjects are summarized in Table 5.
Table 5. Demographic and clinical characteristics in the MS group and healthy controls.
Characteristic Healthy Control (n = 29) Patients with MS (n = 39) p
Age, year 37.79 ± 10.29 38.26 ± 9.05 0.84
Sex, F/M 17/12 23/16 0.98
Years of education 12.10 ± 4.03 11.90 ± 3.68 0.83
Disease duration, month NA 92.33 ± 71.54 NA
Annualized relapse rate NA 0.54 ± 0.46 NA
EDSS score NA 2.24 ± 1.58 NA
HAMA 4.10 ± 3.19 8.33 ± 5.33 <0.01
HAMD 2.00 (0.00–3.50) 6.00 (3.00–10.00) <0.01
Normally-distributed data are the means ± SD and analyzed by the independent-samples t-test.
Non-normally-distributed parameters are the median (interquartile range) and analyzed by the Mann–Whitney
U-test. Abbreviations: EDSS = Expanded Disability Status Scale; HAMA = Hamilton Anxiety Scale;
HAMD = Hamilton Depression Scale; NA = not applicable; F = female; M = male.
4.2. Neuropsychological Evaluation and Clinical Characteristic
The neuropsychological evaluation was modified for the Chinese population based on the Minimal
Assessment of Cognitive Function in Multiple Sclerosis (MACIMS) test. The modified MACIMS has
been previously validated for assessing cognition in MS [16]. The battery consists of five cognitive
domains commonly impaired in MS: the SDMT and PASAT (information processing speed/working
memory), the BVMT-R (visual memory), the JLOT (spatial processing), the TMT (executive function),
and VFT (language ability). We substituted the AVLT-Chinese Edition for the California Verbal
Learning Test-Second Edition (verbal memory).
The raw score obtained from each test was converted into a standardized z-score based on the
mean scores and SD of the HC participants. Patients who exhibited impairment in at least two or more
cognitive domains (scoring at least 1.5 SDs below the mean test value of HCs) were classified as CI [1].
Fourteen patients (35.9%) with MS in our study were classified as CI. MS patients with CI had
a lower level of education and higher EDSS, HAMA and HAMD scores than MS patients with CP,
but there were no significant differences in age, onset age, disease duration, or annualized relapse rate
between the two groups (Table 6).
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Table 6. Demographic and clinical characteristics of the MS patients with CI and CP.
Characteristic Patients with MS (CP) n = 25 Patients with MS (CI) n = 14 p
Age, y 37.92 ± 9.24 38.86 ± 9.02 0.76
Age at onset, y 32.08 ± 10.52 29.71 ± 8.93 0.48
Years of education 13.04 ± 2.99 9.85 ± 3.00 0.01
Disease duration (m) 80.72 ± 71.38 113.07 ± 59.50 0.18
Annualized relapse rate 0.51 ± 0.47 0.58 ± 0.45 0.66
EDSS score 1.00 (1.00–2.00) 3.50 (2.00–4.60) <0.01
HAMA 6.40 ± 3.66 11.79 ± 6.18 <0.01
HAMD 5.12 ± 3.46 9.71 ± 4.53 <0.01
Normally distributed data are the means ± SD and analyzed by the independent-samples t-test.
Non-normally-distributed parameters are the median (interquartile range) and analyzed by the Mann–Whitney
U-test. Abbreviations: CP = cognitive preservation; CI = cognitive impairment; EDSS = Expanded Disability
Status Scale; HAMA = Hamilton Anxiety Scale; HAMD = Hamilton Depression Scale; y = year; m = month.
Correcting for education level, EDSS, HAMA and HAMD scores, MS patients with CI exhibited
worse performance on the Auditory Verbal Learning Test (AVLT), Verbal Fluency Test (VFT),
Brief Visuospatial Memory Test (BVMT), and PASAT 3 seconds (PASAT-3”) tests, compared to the
HC group, and worse performance on the AVLT, VFT, PASAT-3”, BVMT, and Trail making test (TMT)
compared with CP patients. These differences were statistically significant (Table 7).
Table 7. Comparison in cognitive tests among the MS patients with CI, MS patients with CP, and HCs.
Cognitive Test HC (n = 29) Patients with MS (CP) (n = 25) Patients with MS) (CI) (n = 1)
AVLT-Total recall 0.00 ± 1.47 0.05 ± 1.14 −2.33± 1.74 a,c
AVLT-Delayed recall 0.00 ± 1.00 0.20 ± 0.79 −1.74 ± 1.53 a,c
VFT 0.00 ± 1.00 −0.02 ± 0.81 −0.85 ± 0.73 a,c
SDMT 0.00 ± 1.00 −0.19 ± 0.86 −1.97 ± 1.08
TMT-A 0.00 ± 1.00 −0.18 ± 0.66 2.48 ± 2.37 c
TMT-B 0.00 ± 1.00 −0.08 ± 0.65 2.29 ± 2.39 b
BVMT-R-Total recall 0.00 ± 1.00 0.00 ± 1.08 −2.21 ± 1.98 a,c
BVMT-R-Delayed recall 0.00 ± 1.00 0.23 ± 0.85 −2.03 ± 2.13 a,c
PASAT-3” 0.00 ± 1.00 −0.02 ± 0.65 −2.29 ± 1.50 a,c
JLOT 0.00 ± 1.00 0.31 ± 0.781 −0.38 ± 0.68
Values are the mean ± standard deviation (SD); a p < 0.05 compared with HCs; b p < 0.05 compared with
patients with MS and CP; c p < 0.01 compared with patients with MS and CP. Abbreviations: AVLT = Auditory
Verbal Learning Test; VFT = Verbal Fluency Test; SDMT = Symbol digit modalities test; TMT = Trail Making
Test; BVMT-R = Brief Visuo-spatial Memory Test-Revised; PASAT-3”’ = Paced Auditory Serial Addition Test
(3 s); JLOT = Judgment of Line Orientation Test; CI = cognitive impairment; CP = cognitive preservation;
HC = healthy control.
4.3. MRI Image Acquisition and Analysis
Brain images were obtained using a 3.0T MRI (GE 750, Waukesha, WI, USA) with a 32-channel
head coil covering the whole brain. The experimental protocol included DTI images, as well as T1 and
T2-weighted images.
The main sequences were performed with the following parameters:
(1) DTI sequence: echo time (TE) = minimum, repetition time (TR) = 10,000, field of view (FOV)
240 mm, matrix 128 mm × 128 mm, slice thickness 3.0 mm, b-value = 1000, number of slices = 44,
number of directions = 25, and 0 skip between slices.
(2) Three-dimensional T1-weighted magnetization-fast spoiled gradient recalled echo (T1WI
3D-FSPGR) images: TE = min/full, flip angle 8◦, slice thickness 1.2 mm, rep time = 900,
matrix 256 mm × 256 mm, and 0 skip between slices. High-resolution T1-weighted images
were obtained for VBM analyses.
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4.3.1. Diffusion Tensor Images (DTI)
DTI allowed us to quantitatively analyze the microstructural integrity of WM tracts. DTI data
were preprocessed and a range of diffusion metrics, including FA, MD, RD and AD, were analyzed
using the TBSS component of the FMRIB’s Diffusion Toolbox (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/).
The mean FA skeleton was created with a threshold of 0.2, and the TBSS results were analyzed using the
Johns Hopkins University (JHU) International Consortium for Brain Mapping (ICBM)-DTI-81 digital
WM atlas (http://cmrm.med.jhmi.edu/) to identify the specific tracts exhibiting diffusion changes.
Among DTI diffusion metrics, MD reflects the diffusion velocity but not the diffusion direction,
increased AD and RD reflect axonal injury and predominant demyelination respectively, and FA, as a
relative index, is dependent on changes of AD and RD. Thus, decreased FA may suggest microstructural
damage of WM tracts [5,17].
4.3.2. VBM
The obtained T1WI 3D-FSPGR data were preprocessed and analyzed using SPM8-VBM toolboxes
(http://dbm.neuro.uni-jena.de/vbm/). Voxel-by-voxel quantitative analyses of the local volume of
GM between two groups were carried out using VBM.
The routine processing included transforming each participant’s T1 weighted images into the
same stereotactic space, and segmenting all the spatially normalized images into GM, WM and
cerebrospinal fluid (CSF). A modulation step was then performed to moderate the volume changes
caused by spatial normalization. Finally, we smoothed the GM images. We then used SPM8 to perform
voxel-wise statistical analysis on smoothed normalized tissue segments.
Because TBSS and VBM are spatially specific, unbiased, non-hypothesis-driven, and automated
techniques for analyzing MR images, they are more easily reproducible and accurate than
conventional procedures.
4.4. Statistical Analysis
Statistical analyses were performed using SPSS 18.0 for windows (SPSS, Chicago, IL, USA). All of
the parameters were tested for a normal distribution using the Kolmogorov–Smirnov test before the
statistical analysis was conducted. Independent-samples t-tests were used for comparison of normally
distributed parameters, which were presented as means ± SD. Mann–Whitney U-tests were used
for comparison of non-normally distributed parameters, which were presented as median values
(interquartile range). The analyses of DTI and VBM data were performed using two-sample t-tests,
treating age, sex, and education level as covariates. Differences were considered statistically significant
if two-tailed p-values were below 0.05.
5. Conclusions
The current findings indicate that widespread impairment of WM integrity and selective GM
atrophy may be associated with impairment of cognition in RRMS patients.
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Abbreviations
MS Multiple sclerosis
RRMS Relapsing-remitting multiple sclerosis
SPMS secondary-progressive multiple sclerosis
CI Cognitive impairment
CP Cognitive preservation
HC Healthy control
AVLT Auditory verbal learning test
VFT Verbal fluency test
SDMT Symbol digit modalities test
TMT Trail making test
BVMT-R Brief visuo-patial memory test-revised
PASAT Paced auditory serial addition test
JLOT Judgment of line orientation test
DTI Diffusion tensor imaging
FA Fractional anisotropy
MD Mean diffusivity
RD Radial diffusivity
AD Rxial diffusivity
VBM Voxel-based morphometry
WM White matter
GM Grey matter
MACFIMS Minimal assessment of cognitive function in multiple sclerosis
TBSS Tract-based spatial statistics
HAMA Hamilton anxiety scale
HAMD Hamilton depression scale
EDSS Expended disability status scale
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